α2-Macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease

NeuroReport

Volumn 11, Issue 6, 2000, Pages 1167-1171

  Higuchi, Susumu ^a   Matsushita, Sachio ^a   Nakane, Jun ^a   Arai, Hiroyuki ^b   Matsui, Toshifumi ^b   Urakami, Katsuya ^c   Yuzuriha, Takefumi ^d   Takeda, Atsushi ^b  

^a KURIHAMA NATIONAL HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d Hizen National Hospital   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Association study; Caucasian; Japanese; Racial diversity; 2 Macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; ALLELE; ASIAN; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; PARKINSON DISEASE; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALLELES; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; LINKAGE (GENETICS); LOGISTIC MODELS; MALE; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 0034719968     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004270-00005     Document Type: Article

References (24)

1. 1. Blacker D, Wilcox MA, Laird NM et al. Nature Genet 19, 357-360 (1998).
2. 2. Liao A, Nitsch M, Greenberg SM et al. Hum Mol Genet 12, 1953-1956 (1998).
3. 3. Strittmatter WJ, Saunders AM, Schmechel D et al. Proc Natl Acad Sci USA 90, 1977-1981 (1993).
4. 4. Coder EH, Saunders AM, Strittmatter WJ et al. Science 261, 921-923 (1993).
5. 5. Rebeck GW, Harr SD, Strickland DK et al. Ann Neurol 37, 211-217 (1995).
6. 6. Qiu WQ, Borth W, Ye Z et al. J Biol Chem 271, 8443-8451 (1997).
7. 7. Du Y, Ni B, Glinn M et al. J Neurochem 69, 299-305 (1997).
8. 8. Narita M, Holtzman DM, Schwartz AL et al. J Neurochem 69, 1904-1911 (1997).
9. 9. Hughes SR, Khorkova O, Goyal S et al. Proc Natl Acad Sci USA 95, 3275-3280 (1998).
10. 10. Kounnas MZ, Moir RD, Rebeck GW et al. Cell 82, 331-340 (1995).
11. 11. Dow DJ, Lindsey N, Cairns NJ et al. Nature Genet 22, 16-17 (1999).
12. 12. Rudrasingham V, Wavrant-De Vrieze F, Lambert J-C et al. Nature Genet 22, 17-19 (1999).
13. 13. Rogaeva EA, Premkumar S, Grubber J et al. Nature Genet 22, 19-21 (1999).
14. 14. Singleton AB, Gibson AM, McKeith IG et al. Neuroreport 10, 1507-1510 (1999).
15. 15. Chen L, Baum L, Ng H-K et al. Neurosci Lett 269, 173-177 (1999).
16. 16. Crawford F, Town T, Freeman M et al. Neurosci Lett 270, 133-136 (1999).
17. 17. McKhann G, Drachman D, Folstein M et al. Neurology 34, 939-944 (1984).
18. 18. Folstein MF, Folstein SE and McHugh PR. J Psychiatr Res 12, 189-198 (1975).
19. 19. Stem MB, Gur RC, Saykin AJ et al. J Am Ger Soc 34, 475-478 (1986).
20. 20. Wenham PR and Price WH. Lancet 337, 1158-1159 (1991).
21. 21. Chen WJ, Lu M-L, Hsu Y-PP et al. Am J Med Genet 74, 129-136 (1997).
22. 22. Lin-Lee YC, Kao FT, Cheung P et al. Biochemistry 24, 3751-3756 (1985).
23. 23. Kan CC, Solomon E, Belt KT et al. Proc Natl Acad Sci USA 82, 2282-2286 (1985).
24. 24. Myllykangas L, Polvikoski T, Sulkava R et al. Ann Neurol 46, 382-390 (1999).